KIRSTEN RUHL: Open Payments
NPI 1003221193 · FLORHAM PARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $99 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $173 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Lilly USA, LLC | 2 | $40 |
| Dexcom, Inc. | 1 | $35 |
| PFIZER INC. | 2 | $34 |
| Novo Nordisk Inc | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Echosens North America, Inc. | 1 | $13 |
Products named: FREESTYLE LIBRE 3, BREZTRI, ZEPBOUND, Dexcom G6 Transmitter, PREVNAR 20, Wegovy, Symbravo, Fibroscan.
Industry payments across NJ — which companies pay providers there.
